August 14, 2017 / 7:38 PM / 2 years ago

BRIEF-Aethlon Medical received formal receipt from FDA for expedited access pathway program submission ‍​

Aug 14 (Reuters) - Aethlon Medical Inc:

* On Aug 14, co received formal receipt from the U.S. FDA for expedited access pathway program submission ‍​

* Submission formally requests that the Aethlon Hemopurifier be included in the FDA EAP program - SEC filing‍​ Source text: (bit.ly/2uIjrkU) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below